Zobrazeno 1 - 10
of 205
pro vyhledávání: '"Thomas H Taylor"'
Autor:
Westyn Branch-Elliman, Ryan Ferguson, Gheorghe Doros, Patricia Woods, Sarah Leatherman, Judith Strymish, Rupak Datta, Rekha Goswami, Matthew D Jankowich, Nishant R Shah, Thomas H Taylor, Sarah T Page, Sara J Schiller, Colleen Shannon, Cynthia Hau, Maura Flynn, Erika Holmberg, Karen Visnaw, Rupali Dhond, Mary Brophy, Paul A Monach
Publikováno v:
PLoS ONE, Vol 17, Iss 2, p e0263591 (2022)
Importance and objectiveThe aim of this pragmatic, embedded, adaptive trial was to measure the effectiveness of the subcutaneous anti-IL-6R antibody sarilumab, when added to an evolving standard of care (SOC), for clinical management of inpatients wi
Externí odkaz:
https://doaj.org/article/0f93913ce462481c84ad214cf1534dd7
Autor:
Jeni Vuong, Jean-Marc Collard, Melissa J Whaley, Issaka Bassira, Issaka Seidou, Seydou Diarra, Rasmata T Ouédraogo, Dinanibè Kambiré, Thomas H Taylor, Claudio Sacchi, Leonard W Mayer, Xin Wang
Publikováno v:
PLoS ONE, Vol 11, Iss 2, p e0147765 (2016)
Neisseria meningitidis (Nm), Haemophilus influenzae (Hi), and Streptococcus pneumoniae (Sp) are the lead causes of bacterial meningitis. Detection of these pathogens from clinical specimens using traditional real-time PCR (rt-PCR) requires DNA extrac
Externí odkaz:
https://doaj.org/article/08c5d1185e3f42b99c069b14c3433a9a
Autor:
Oliver W Morgan, Anna Bramley, Ashley Fowlkes, David S Freedman, Thomas H Taylor, Paul Gargiullo, Brook Belay, Seema Jain, Chad Cox, Laurie Kamimoto, Anthony Fiore, Lyn Finelli, Sonja J Olsen, Alicia M Fry
Publikováno v:
PLoS ONE, Vol 5, Iss 3, p e9694 (2010)
BACKGROUND: Severe illness due to 2009 pandemic A(H1N1) infection has been reported among persons who are obese or morbidly obese. We assessed whether obesity is a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1), inde
Externí odkaz:
https://doaj.org/article/7798cf0e2bbb405e8305ed1c2c8920d9
Autor:
Daniela A. Bota, Thomas H. Taylor, David E. Piccioni, Christopher M. Duma, Renato V. LaRocca, Santosh Kesari, Jose A. Carrillo, Mehrdad Abedi, Robert D. Aiken, Frank P. K. Hsu, Xiao-Tang Kong, Candace Hsieh, Peter G. Bota, Gabriel I. Nistor, Hans S. Keirstead, Robert O. Dillman
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 41, Iss 1, Pp 1-9 (2022)
Abstract Background Vaccine immunotherapy may improve survival in Glioblastoma (GBM). A multicenter phase II trial was designed to determine: (1) the success rate of manufacturing the Aivita GBM vaccine (AV-GBM-1), (2) Adverse Events (AE) associated
Externí odkaz:
https://doaj.org/article/5a31d54aac0647619b0bae78c1eddb03
Publikováno v:
JAAD International, Vol 9, Iss , Pp 26-27 (2022)
Externí odkaz:
https://doaj.org/article/e45883fe12a84fb6b62267ab36db80d3
Autor:
Daniela A. Bota, Thomas H. Taylor, Naomi Lomeli, Xiao-Tang Kong, Beverly D. Fu, Axel H. Schönthal, Samuel Singer, Deborah T. Blumenthal, Frank M. Senecal, Helena Linardou, Evangelos Rokas, Dimitris G. Antoniou, Virgil E. J. C. Schijns, Thomas C. Chen, Joseph Elliot, Apostolos Stathopoulos
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundGlioblastoma (GBM) is the most common primary, malignant brain tumor in adults and has a poor prognosis. The median progression-free survival (mPFS) of newly diagnosed GBM is approximately 6 months. The recurrence rate approaches 100%, and
Externí odkaz:
https://doaj.org/article/797a63071f0044c39c85c3954e4ac46c
Publikováno v:
Currents in Pharmacy Teaching and Learning. 14:1015-1020
Inpatient medication order verification is an important skill for pharmacy students to learn for patient safety. This article describes a systematic approach to order verification that enables students to apply didactic knowledge and determine the pr
Autor:
Farshid Dayyani, Jasmine Balangue, Jennifer Valerin, Matthew J. Keating, Jason A. Zell, Thomas H. Taylor, May T. Cho
This study determined the safety and Recommended Phase 2 Dose (RP2D) of the multi-kinase inhibitor cabozantinib in combination with trifluridine/tipiracil (TFT/TPI) in refractory metastatic colorectal carcinoma (mCRC). Single institution investigator
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::777dd0657bd8c630779fc68e55aae39a
https://doi.org/10.21203/rs.3.rs-2739109/v1
https://doi.org/10.21203/rs.3.rs-2739109/v1
Autor:
Frank L. Meyskens, Alexander Ross Kerr, Lori J. Wirth, William Jarrard Goodwin, Francisco Civantos, Marjorie Perloff, Anh D. Le, Mai Gu, Diana V. Messadi, Raymond J. Melrose, Ann R. Kennedy, Thomas H. Taylor, William B. Armstrong
PDF - 140K, Characteristics of Placebo. In this section, estimates are given for the molar concentrations of certain compounds in BBIC and the Masa Harina placebo in the mouth and in the body of the oral leukoplakia patients.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e58e305a1a0fe6014c4a9148c9d9bef
https://doi.org/10.1158/1940-6207.22523316
https://doi.org/10.1158/1940-6207.22523316
Autor:
Frank L. Meyskens, Alexander Ross Kerr, Lori J. Wirth, William Jarrard Goodwin, Francisco Civantos, Marjorie Perloff, Anh D. Le, Mai Gu, Diana V. Messadi, Raymond J. Melrose, Ann R. Kennedy, Thomas H. Taylor, William B. Armstrong
PDF - 59K, Analysis of Sample Size if Placebo was 30 percent. Point one: formerly studies were powered anticipating a response rate in the placebo of about 10%. Power estimates for our Phase IIB study were performed by the dose-response observed in o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c96244b5a92bdc6f8e34414c9b28602
https://doi.org/10.1158/1940-6207.22523310.v1
https://doi.org/10.1158/1940-6207.22523310.v1